Ticker
NRXSCompany Name
NEURAXIS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 24.55M | $ 5M | $ -127.2K | $ 0 | -19.85% |
3/31/2025 | $ 16.74M | $ 0 | $ 3.27M | $ 0 | -19.5% |
12/31/2024 | $ 16.38M | $ 0 | $ 4.66M | $ 0 | -28.44% |
9/30/2024 | $ 22.06M | $ 1.8M | $ 5.03M | $ 0 | -30.96% |
6/30/2024 | $ 21.28M | $ 4.85M | $ 5.45M | $ 0 | -48.41% |
3/31/2024 | $ 19.74M | $ 4.85M | $ 2.91M | $ 0 | -39.28% |
12/31/2023 | $ 20.62M | $ 4.85M | $ 2.09M | $ 0 | -33.62% |
9/30/2023 | $ 12.38M | $ 3.05M | $ 2.74M | $ 0 | -46.75% |
6/30/2023 | $ 16.69M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2022 | $ 0 | $ 0 | $ 3.03M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for NEURAXIS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 151.09K ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |